The Board granted service connection for myelodysplastic syndrome (MDS) due to the Veteran's in-service Agent Orange exposure.
The deciding factor: The evidence of record, including a positive nexus opinion from a June 2024 VA examiner, supports the conclusion that the Veteran's MDS is related to his in-service herbicide agent exposure.
- Claimed conditions
- myelodysplastic syndrome (MDS)
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- October 7, 2024
- Citation
- A24063622
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board remands the appeal for a new VA medical opinion regarding the etiology of the Veteran's MDS and potential AML and b-cell leukemia due to inadequacies in previous opinions.
- Granted
The Board granted service connection for myelodysplastic syndrome (MDS), to include anaplastic anemia, due to toxic exposure at Fort McClellan.
- Granted
The Board granted service connection for myelodysplastic syndrome based on the Veteran's exposure to contaminated water at Camp Lejeune during his military service.
- Denied
The Board denied service connection for myelodysplastic syndrome (MDS) as it was not shown to be related to the Veteran's service or any toxic exposure.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.